| Evaluation of PD-L1 (Programmed Death-Ligand 1) Tumor Expression in Patients With Large-cell Neuroendocrine Carcinoma (NEC) (NCT03305133) | Groupe Francais De Pneumo-Cancerologie | 2017-09-26 |
| Icotinib for Completed Resected IB NSCLC With EGFR Mutation (NCT02264210) | Sun Yat-sen University | 2015-01-01 |
| S1300: Pemetrexed Disodium With or Without Crizotinib in Treating Patients With Stage IV Non-Small Cell Lung Cancer That Has Progressed After Crizotinib (NCT02134912) | SWOG Cancer Research Network | 2014-08-01 |
| Phase I IGART Study Using Active Breathing Control and Simultaneous Boost for Patients With NSCLC (NCT02059967) | Virginia Commonwealth University | 2014-03-01 |
| Image-Guided Hypofractionated Radiation Therapy With Stereotactic Body Radiation Therapy Boost and Combination Chemotherapy in Treating Patients With Stage II-III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery (NCT01345851) | Jonsson Comprehensive Cancer Center | 2011-03-23 |
| Docetaxel, Cisplatin, Pegfilgrastim, and Erlotinib Hydrochloride in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer (NCT01557959) | Wake Forest University Health Sciences | 2007-07-01 |
| S0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung Cancer (NCT00368992) | National Cancer Institute (NCI) | 2006-08-01 |
| Docetaxel With Either Cetuximab or Bortezomib as First-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer (NCT00118183) | National Cancer Institute (NCI) | 2005-07-01 |
| S0341: Erlotinib in Treating Patients With Advanced Primary Non-Small Cell Lung Cancer (NCT00087412) | National Cancer Institute (NCI) | 2004-09-01 |
| Photodynamic Therapy in Treating Patients With Lung Cancer (NCT01668823) | Roswell Park Cancer Institute | 2004-02-01 |
| Gefitinib in Treating Patients With Stage IB, II, or IIIA Non-small Cell Lung Cancer That Was Completely Removed by Surgery (NCT00049543) | National Cancer Institute (NCI) | 2002-09-01 |
| Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer (NCT00021060) | National Cancer Institute (NCI) | 2002-08-01 |
| Combination Chemotherapy, Radiation Therapy, and Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer (NCT00040794) | National Cancer Institute (NCI) | 2002-05-01 |
| Combination Chemotherapy and Radiation Therapy With or Without Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery (NCT00020709) | National Cancer Institute (NCI) | 2001-06-01 |
| Combination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery (NCT00005838) | National Cancer Institute (NCI) | 2000-03-01 |
| Surgery With or Without Chemotherapy in Treating Patients With Stage I Non-small Cell Lung Cancer (NCT00002852) | National Cancer Institute (NCI) | 1996-10-01 |